Brazilian regulator rejects use of Russia's Sputnik V COVID-19 vaccine

"Due to the lack of consistent and reliable data, Anvisa's Board of directors unanimously decided not to recommend the exceptional importation of the Russian Sputnik V vaccine," the watchdog said on Monday.